|
Liverpool at forefront of
latest developments in cancer care
PROTON Partners International Ltd, the
company building a ₤35 million cancer centre in Liverpool, is set to outline why
the North West is leading the way in the bringing the latest cancer treatment
and research to the North West Region of England.
Led by Liverpool-born CEO Mike Moran, the company has successfully received
formal planning permission to build an Oncology Centre, in Liverpool, known as:-
'The Rutherford Cancer Centre North West.' The Centre will be part of the new ₤1
billion Knowledge Quarter (KQ) in Paddington Village.
Proton Partners International is also developing a Genomics Research Centre in
the City's Life Sciences Accelerator building. The programme will be the 1st
part of a Health Campus, set to surround the ₤335m new Royal Liverpool Hospital.
Additionally, Proton Partners International has also agreed to a 2 year
collaborative research project with The University of Liverpool, to develop a new
measurement system, known as a 3D Water Phantom, to enhance proton beam therapy
technology.
The company, which is also building centres in Newport, Northumberland and
Reading, have been sharing its plans for the region at the NCRI Cancer Conference,
that has
taken place at the BT Convention Centre.
The Rutherford Cancer Centre North West will bring the most advanced treatments
in cancer care to the North West, including high energy proton beam therapy (a
treatment not currently available in the UK), as well as the latest technology
on the market to deliver:- radiotherapy, chemotherapy, imaging and diagnostics.
The conventional treatments will be available from late 2018 and high energy
proton beam therapy will be available from mid- 019.
The Rutherford Cancer Centre North West will treat up to 500 patients a year and
treatment will be available to medically insured private patients, self paying
patients and patients referred by the NHS.
Mike Moran, CEO of Proton Partners International, said:- "We are proud to
showcase our plans for Liverpool and the UK at this year's NCRI Cancer
Conference.
Our mission is to make the best cancer care accessible to patients across the
country and being from Liverpool myself, I'm incredibly proud that my City is
not only leading the way in advancing treatment provision, but it is also at the
forefront of world leading research projects."
The company's 1st centre in Newport, The Rutherford Cancer Centre South Wales,
recently opened to treat patients with chemotherapy and radiotherapy, and the
high energy proton beam therapy system is currently undergoing installation.
The NCRI Cancer Conference, at the BT Convention Centre over 5 November to 8
November 2017, has attracted over 1,500 delegates and provided a platform for
researchers, clinicians and industry representatives to discuss,
present and future therapies, along with showcasing high quality research.
|
